130 related articles for article (PubMed ID: 7807664)
1. New therapeutic strategies for patients with gastrointestinal malignancies using biochemical modulation of fluorouracil.
Allegra CJ
JAMA; 1995 Jan; 273(3):236-9. PubMed ID: 7807664
[No Abstract] [Full Text] [Related]
2. The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid).
Cantwell BM; Harris AL
Br J Cancer; 1988 Aug; 58(2):189-90. PubMed ID: 3166908
[No Abstract] [Full Text] [Related]
3. Selectivity of CF and 5-fluorouracil: critical role of polyglutamylation.
Houghton JA; Williams LG; deGraaf SS; Radparvar S; Wainer IW; Rodman JR; Houghton PJ
Adv Exp Med Biol; 1988; 244():85-95. PubMed ID: 3266830
[No Abstract] [Full Text] [Related]
4. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma.
Gorlick R; Metzger R; Danenberg KD; Salonga D; Miles JS; Longo GS; Fu J; Banerjee D; Klimstra D; Jhanwar S; Danenberg PV; Kemeny N; Bertino JR
J Clin Oncol; 1998 Apr; 16(4):1465-9. PubMed ID: 9552053
[TBL] [Abstract][Full Text] [Related]
5. Interaction between 5-fluorouracil, [6RS]leucovorin, and recombinant human interferon-alpha 2a in cultured colon adenocarcinoma cells.
Houghton JA; Adkins DA; Rahman A; Houghton PJ
Cancer Commun; 1991 Jul; 3(7):225-31. PubMed ID: 1867955
[TBL] [Abstract][Full Text] [Related]
6. Effect of leucovorin on 5-fluorouracil induced inhibition of thymidylate synthase in patients with colon cancer.
Peters GJ; van Groeningen CJ; van der Wilt CL; Smid K; Meijer S; Pinedo HM
Adv Exp Med Biol; 1991; 309A():131-4. PubMed ID: 1789191
[No Abstract] [Full Text] [Related]
7. The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.
Köhne CH; Wilke H; Schöffski P; Schmoll HJ
J Infus Chemother; 1996; 6(4):206-10. PubMed ID: 9229317
[No Abstract] [Full Text] [Related]
8. Liver resection after FOLFOX with bevacizumab.
Mickle M; Mulcahy MF
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
[No Abstract] [Full Text] [Related]
9. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
Chang YY; Lin JK; Jiang JK
Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
[No Abstract] [Full Text] [Related]
11. Comparison of continuous infusions and bolus injections of 5-fluorouracil with or without leucovorin: implications for inhibition of thymidylate synthase.
Peters GJ; Codacci-Pisanelli G; van der Wilt CL; van Laar JA; Smid K; Noordhuis P; Pinedo HM
Adv Exp Med Biol; 1993; 339():9-20; discussion 21. PubMed ID: 8178733
[No Abstract] [Full Text] [Related]
12. A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report.
Aquino A; Prete SP; Balduzzi A; Fossile E; Formica V; Torino F; Bonmassar L; Di Giacomo A; Cappelletti D; Cardillo A; Graziani G
J Chemother; 2002 Aug; 14(4):412-6. PubMed ID: 12420861
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil.
Cascinu S; Aschele C; Barni S; Debernardis D; Baldo C; Tunesi G; Catalano V; Staccioli MP; Brenna A; Muretto P; Catalano G
Clin Cancer Res; 1999 Aug; 5(8):1996-9. PubMed ID: 10473077
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of a new inhibitor of thymidylate synthase: 'Tomudex' (raltitrexed).
Cunningham D
Tumori; 1997; 83(1 Suppl):S70-1. PubMed ID: 9154074
[No Abstract] [Full Text] [Related]
15. Biochemical and pharmacologic basis for potentiation of 5-fluorouracil action by leucovorin.
Rustum YM; Trave F; Zakrzewski SF; Petrelli N; Herrera L; Mittelman A; Arbuck SG; Creaven PJ
NCI Monogr; 1987; (5):165-70. PubMed ID: 2448653
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma.
Alexander HR; Grem JL; Hamilton JM; Pass HI; Hong M; Fraker DL; Steinberg SM; McAtee N; Allegra BC; Johnston PG
Cancer J Sci Am; 1995; 1(1):49-54. PubMed ID: 9166454
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
18. Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis.
Kobayashi H; Sugihara K; Uetake H; Higuchi T; Yasuno M; Enomoto M; Iida S; Azuma M; Mori R; Omori A; Lenz HJ; Danenberg KD; Danenberg PV
Int J Oncol; 2008 Dec; 33(6):1257-62. PubMed ID: 19020759
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and antitumor effects of 5,8-dideazaisopteroylglutamate, a unique quinazoline inhibitor of thymidylate synthase.
Fernandes DJ; Bertino JR; Hynes JB
Cancer Res; 1983 Mar; 43(3):1117-23. PubMed ID: 6825083
[No Abstract] [Full Text] [Related]
20. 5-Fluorouracil plus leucovorin as adjuvant treatment of an experimental liver tumor in rats.
Carlsson G; Gustavsson BG; Spears CP; Hafström LO
Anticancer Res; 1990; 10(3):813-6. PubMed ID: 2369095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
